Literature DB >> 10944705

Primary sclerosing cholangitis.

S A Mitchell1, R W Chapman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944705     DOI: 10.1385/CRIAI:18:2:185

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  119 in total

1.  Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis.

Authors:  J A Snook; R W Chapman; G K Sachdev; A Heryet; P M Kelly; K A Fleming; D P Jewell
Journal:  J Hepatol       Date:  1989-07       Impact factor: 25.083

2.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

Authors:  J Satsangi; K I Welsh; M Bunce; C Julier; J M Farrant; J I Bell; D P Jewell
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

3.  HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.

Authors:  W Z Mehal; Y M Lo; B P Wordsworth; J M Neuberger; S C Hubscher; K A Fleming; R W Chapman
Journal:  Gastroenterology       Date:  1994-01       Impact factor: 22.682

4.  Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease.

Authors:  K Hata; D H Van Thiel; R B Herberman; T L Whiteside
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

Review 5.  Gamma delta cells regulate autoimmunity.

Authors:  A Hayday; L Geng
Journal:  Curr Opin Immunol       Date:  1997-12       Impact factor: 7.486

6.  A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis.

Authors:  T A Knox; M M Kaplan
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

7.  Risk factors in primary sclerosing cholangitis.

Authors:  E Schrumpf; M Abdelnoor; O Fausa; K Elgjo; E Jenssen; F Kolmannskog
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

8.  Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver.

Authors:  A Escorsell; A Parés; J Rodés; J A Solís-Herruzo; M Miras; E de la Morena
Journal:  J Hepatol       Date:  1994-11       Impact factor: 25.083

9.  Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients.

Authors:  J H Helzberg; J M Petersen; J L Boyer
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

10.  Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.

Authors:  S Bloom; K Fleming; R Chapman
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.